Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Erdal (Bergen, Norway), A. Johannessen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), A. Gulsvik (Bergen, Norway), J. Askildsen (Bergen, Norway), R. Grønseth (Bergen, Norway). Costs of COPD exacerbations in a general population.. 3157

Member's Comments

No comment yet.

Related content which might interest you: COPD exacerbations and predictors in a general population Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Costs of exacerbations in COPD Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012 The costs of exacerbations in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 273s Year: 2001 How common is exacerbations in COPD in a general population sample? Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Incidence of asthma and COPD in a general population Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Hospitalization cost analysis due to acute COPD exacerbations Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Costs of COPD and asthma in Sweden Source: Eur Respir J 2004; 24: Suppl. 48, 701s Year: 2004 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Antibiotics prescriptions increased medical costs for COPD exacerbations. Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study Source: International Congress 2014 – New insights into the epidemiology of COPD Year: 2014 COPD care programme can reduce readmissions and in-patient bed days Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Factors associated with COPD exacerbation frequency in a UK primary care cohort Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013